Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ESPR

Esperion Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · ESPR

All alert types
3.18 USD 0.00 0.00%
As of Jul 13, 2026 Extended hours 3.15 -0.94%
Bid
3.15 × 2
Ask
3.16 × 2
3.18 Day range 3.18
1.58 52-week range 3.94
YTD
-14.05%
1 year
+211.76%
Open
3.18
Prev close
3.18
Mkt cap
441.36M
Vol
0
Avg vol
5.64M
EPS
-0.67
P/E
0.00
Div yield
0.00%
More statistics
Low
3.18
High
3.18
Forward P/E
11.20
Beta
0.95
Short ratio
5.70
Inst. own
66.34%
Dividend
0.00
Ex-div date
50-d avg
2.41
200-d avg
2.24
1y target
7.51

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ESPR has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-2.88 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -33.6×
FY 2016: -3.8×FY 2017: -9.4×FY 2018: -6.1×FY 2019: -14.8×FY 2020: -4.3×FY 2021: -0.5×FY 2022: -1.4×FY 2023: -1.5×FY 2024: -7.9×FY 2025: -33.6×
FY 2016 5y median -1.5× FY 2025
P/S 1.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 6.7×FY 2019: 10.9×FY 2020: 3.1×FY 2021: 1.8×FY 2022: 5.5×FY 2023: 2.7×FY 2024: 1.2×FY 2025: 1.9×
FY 2016 5y median 1.9× FY 2025
P/B -2.5×
FY 2016: 1.2×FY 2017: 6.4×FY 2018: -2.1×FY 2019: 81.0×FY 2020: -7.4×FY 2021: -0.7×FY 2022: -1.3×FY 2023: -0.7×FY 2024: -1.1×FY 2025: -2.5×
FY 2016 5y median -1.1× FY 2025
P/FCF -58.7×
FY 2016: -5.9×FY 2017: -12.0×FY 2018: -8.3×FY 2019: -22.7×FY 2020: -7.2×FY 2021: -0.5×FY 2022: -2.4×FY 2023: -2.3×FY 2024: -17.2×FY 2025: -58.7×
FY 2016 5y median -2.4× FY 2025
EV/EBITDA 18.0×
FY 2016: -3.3×FY 2017: -9.3×FY 2018: -5.8×FY 2019: -16.4×FY 2020: -4.9×FY 2021: -0.9×FY 2022: -3.1×FY 2023: -5.1×FY 2024: 113×FY 2025: 18.0×
FY 2016 5y median -0.9× FY 2025
EV/Sales 2.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 6.5×FY 2019: 9.8×FY 2020: 2.6×FY 2021: 2.5×FY 2022: 7.3×FY 2023: 6.6×FY 2024: 2.6×FY 2025: 2.9×
FY 2016 5y median 2.9× FY 2025
FCF Yield -1.7%
FY 2016: -16.9%FY 2017: -8.3%FY 2018: -12.1%FY 2019: -4.4%FY 2020: -13.8%FY 2021: -182.6%FY 2022: -42.3%FY 2023: -43.9%FY 2024: -5.8%FY 2025: -1.7%
FY 2016 5y median -42.3% FY 2025

Profitability

Gross Margin 67.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 99.9%FY 2019: 100.0%FY 2020: 98.9%FY 2021: 81.9%FY 2022: 64.3%FY 2023: 62.8%FY 2024: 79.4%FY 2025: 67.9%
FY 2016 5y median 67.9% FY 2025
Operating Margin 15.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -110.9%FY 2019: -62.8%FY 2020: -53.3%FY 2021: -289.0%FY 2022: -237.8%FY 2023: -133.7%FY 2024: 16.4%FY 2025: 15.0%
FY 2016 5y median -133.7% FY 2025
Net Margin -5.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -109.4%FY 2019: -65.5%FY 2020: -63.1%FY 2021: -343.0%FY 2022: -309.6%FY 2023: -179.9%FY 2024: -15.6%FY 2025: -5.6%
FY 2016 5y median -179.9% FY 2025
ROE 7.5%
FY 2016: -32.8%FY 2017: -68.2%FY 2018: 33.7%FY 2019: -487.0%FY 2020: 149.3%FY 2021: 136.6%FY 2022: 72.2%FY 2023: 46.0%FY 2024: 13.3%FY 2025: 7.5%
FY 2016 5y median 46.0% FY 2025
ROIC 23.5%
FY 2016: -32.9%FY 2017: -68.8%FY 2018: -258.6%FY 2019: -62.6%FY 2020: -46.4%FY 2021: -70.3%FY 2022: -99.1%FY 2023: -181.0%FY 2024: 26.9%FY 2025: 23.5%
FY 2016 5y median -70.3% FY 2025
ROA -4.9%
FY 2016: -30.6%FY 2017: -60.1%FY 2018: -140.7%FY 2019: -45.3%FY 2020: -40.6%FY 2021: -70.5%FY 2022: -94.2%FY 2023: -101.7%FY 2024: -15.0%FY 2025: -4.9%
FY 2016 5y median -70.5% FY 2025

Growth (YoY)

Revenue 21.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -19.6%FY 2020: 53.4%FY 2021: -65.5%FY 2022: -3.8%FY 2023: 54.1%FY 2024: 185.7%FY 2025: 21.3%
FY 2016 FY 2025
Operating Income 10.8%
FY 2016: -52.2%FY 2017: -121.9%FY 2018: -21.1%FY 2019: 54.5%FY 2020: -30.4%FY 2021: -86.8%FY 2022: 20.8%FY 2023: 13.3%FY 2024: 135.0%FY 2025: 10.8%
FY 2016 FY 2025
EPS (diluted) 60.7%
FY 2016: -47.3%FY 2017: -109.6%FY 2018: -8.0%FY 2019: 46.7%FY 2020: -50.5%FY 2021: -82.3%FY 2022: 60.7%FY 2023: 53.1%FY 2024: 86.2%FY 2025: 60.7%
FY 2016 FY 2025
Free Cash Flow 45.4%
FY 2016: -24.3%FY 2017: -174.6%FY 2018: -13.3%FY 2019: 52.1%FY 2020: -38.2%FY 2021: -167.7%FY 2022: 33.7%FY 2023: 22.5%FY 2024: 82.3%FY 2025: 45.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.5×
FY 2016: 13.7×FY 2017: 6.2×FY 2018: 2.2×FY 2019: 3.2×FY 2020: 3.7×FY 2021: 4.5×FY 2022: 2.7×FY 2023: 1.3×FY 2024: 1.4×FY 2025: 1.5×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.2×
FY 2016: 13.7×FY 2017: 6.2×FY 2018: 2.2×FY 2019: 3.2×FY 2020: 3.5×FY 2021: 4.0×FY 2022: 2.3×FY 2023: 0.9×FY 2024: 1.0×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
Debt / Equity -1.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: -1.9×FY 2021: -1.3×FY 2022: -0.8×FY 2023: -1.2×FY 2024: -1.5×FY 2025: -1.8×
FY 2016 5y median -1.3× FY 2025
Net Debt / EBITDA 6.0×
FY 2016: 0.5×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 1.9×FY 2020: 1.0×FY 2021: -0.2×FY 2022: -0.8×FY 2023: -3.1×FY 2024: 59.0×FY 2025: 6.0×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 0.7×
FY 2016: -203×FY 2017: -853×FY 2018: -2046×FY 2019: -11.5×FY 2020: -5.4×FY 2021: -4.9×FY 2022: -3.2×FY 2023: -2.6×FY 2024: 0.9×FY 2025: 0.7×
FY 2016 5y median -2.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31